Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Alumis IncALMS | $16.23 | Strong Buy | $39.00 | +140.30% | 2 days ago | |
Analyst RankingTop 3% #109 out of 5165 analysts Average Return+28.12% Win Rate60%98 out of 162 Risk vs RewardPoor Good Analyst ColorWells Fargo's Derek Archila raised their price target on Alumis (NASDAQ: ALMS) by 129.4% from $17 to $39 on 2026/01/06. The analyst maintained their Strong Buy rating on the stock. Archila backgrounded that their price target hike followed Alumis' announcement of positive topline results from its Phase 3 ONWARD1 and ONWARD2 clinical trials of envudeucitinib, a next-gen highly selective oral tyrosine kinase 2 inhibitor, in patients with moderate-to-severe plaque psoriasis. The analyst said they anticipate that envudeucitinib will be a formidable rival in the PsO market, noting that the PsO data it has produced thus far could boost the investment narrative beyond its initial SLE-centric thesis. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to ? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.